针对衰弱和衰弱前期急性心血管病老年患者的多组分干预:TARGET-EFT随机临床试验
这项单中心随机对照试验纳入142例因急性心血管病住院的衰弱或衰弱前期老年患者(平均年龄79.5岁),评估院内多组分干预对比常规照护对患者中心结局的影响。结果显示干预改善了30天出院后健康相关生活质量和出院时情绪评分,但未改善残疾评分,且无干预相关不良事件。
要点
- 院内多组分干预可改善衰弱老年心血管病患者的健康相关生活质量和情绪。
- 干预未显著改善30天出院后残疾评分。
- 干预安全性良好,无干预相关不良事件。
核心结论
- 在因急性心血管病住院的衰弱老年患者中,针对衰弱的多组分院内干预安全,并对健康相关生活质量和心理健康带来适度但有临床意义的改善。
研究设计与样本
- 单中心平行组随机临床试验,纳入经Essential Frailty Toolset评估为衰弱或衰弱前期的急性心血管病老年患者,随机分为常规照护组或多组分干预组,共142例,平均年龄79.5岁,55%为女性。
主要发现
- 干预组健康相关生活质量(EQ-5D-5L评分)较常规照护组改善(系数0.08;95%CI 0.01, 0.15;p=0.03)。
- 干预组出院时情绪困扰(医院焦虑抑郁量表评分)较常规照护组改善(系数-1.95;95%CI -3.82, -0.09;p=0.04)。
- 干预组残疾评分(Older Americans Resources and Services评分)与常规照护组无显著差异(系数0.18;95%CI -1.44, 1.81;p=0.82)。
- 无干预相关不良事件报告。
关键数值与推荐
- 主要诊断分布:心力衰竭29%、瓣膜性心脏病28%、缺血性心脏病14%、心律失常11%、其他心血管病18%。
临床怎么用
- 对因急性心血管病住院的衰弱或衰弱前期老年患者,可考虑实施针对躯体虚弱、认知障碍、营养不良和贫血的院内多组分干预,以改善生活质量和情绪。
局限性
- 研究为单中心设计,向其他医疗体系的推广性有待评估。
- 干预对无事件生存和功能状态的下游影响尚需未来研究评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hospitalization for cardiovascular disease (CVD) may be complicated by hospital-acquired disability (HAD) and subsequently poor health-related quality of life (HRQOL). While frailty has been shown to be a risk factor, it has yet to be studied as a therapeutic target to improve outcomes. OBJECTIVES: This trial sought to determine the effects of an in-hospital multicomponent intervention targeting physical weakness, cognitive impairment, malnutrition, and anemia on patient-centered outcomes compared to usual care. METHODS: A single-center parallel-group randomized clinical trial was conducted in older patients with acute CVD and evidence of frailty or pre-frailty as measured by the Essential Frailty Toolset (EFT). Patients were randomized to usual care or a multicomponent intervention. Outcomes were HRQOL (EQ-5D-5L score) and disability (Older Americans Resources and Services score) at 30 days post-discharge and mood disturbances (Hospital Anxiety and Depression Scale) at discharge. RESULTS: The trial cohort consisted of 142 patients with a mean age of 79.5 years and 55% females. The primary diagnosis was heart failure in 29%, valvular heart disease in 28%, ischemic heart disease in 14%, arrhythmia in 11%, and other CVDs in 18%. The intervention improved HRQOL scores (coefficient 0.08; 95% CI 0.01, 0.15; p = 0.03) and mood scores (coefficient -1.95; 95% CI -3.82, -0.09; p = 0.04) but not disability scores (coefficient 0.18; 95% CI -1.44, 1.81; p = 0.82). There were no intervention-related adverse events. CONCLUSION: In frail older patients hospitalized for acute CVDs, an in-hospital multicomponent intervention targeted to frailty was safe and led to modest yet clinically meaningful improvements in HRQOL and mental well-being. The downstream impact of these effects on event-free survival and functional status remains to be evaluated in future research, as does the generalizability to other healthcare systems. CLINICAL REGISTRATION NUMBER: NCT04291690.
引用
- Fountotos R, Ahmad F, Bharaj N, et al. Multicomponent intervention for frail and pre-frail older adults with acute cardiovascular conditions: The TARGET-EFT randomized clinical trial. J Am Geriatr Soc. 2023. PMID: 36645227. doi:10.1111/jgs.18228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。